| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |